| [1] |
Kan W, Qu M J, Wang Y Y, et al. A review of type 2 diabetes mellitus and cognitive impairment[J]. Front Endocrinol, 2025, 16: 1624472. DOI: 10.3389/fendo.2025.1624472.
|
| [2] |
Koekkoek P S, Kappelle L J, Van Den Berg E, et al. Cognitive function in patients with diabetes mellitus: guidance for daily care[J]. Lancet Neurol, 2015, 14(3): 329-340. DOI: 10.1016/S1474-4422(14)70249-2.
|
| [3] |
Jia L F, Du Y F, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study[J]. Lancet Public Health, 2020, 5(12): e661-e671. DOI: 10.1016/S2468-2667(20)30185-7.
|
| [4] |
Ji X L, Gao H, Sun D Y, et al. Trajectories of cognition and daily functioning before and after incident diabetes[J]. Diabetes Care, 2023, 46(1): 75-82. DOI: 10.2337/dc22-1190.
|
| [5] |
Chen Q M, Zhu S J, Shang J, et al. Trends in cognitive function before and after diabetes onset: the China health and retirement longitudinal study[J]. Neurology, 2024, 102(7): e209165. DOI: 10.1212/WNL.0000000000209165.
|
| [6] |
Biessels G J, Whitmer R A. Cognitive dysfunction in diabetes: how to implement emerging guidelines[J]. Diabetologia, 2020, 63(1): 3-9. DOI: 10.1007/s00125-019-04977-9.
|
| [7] |
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission[J]. Lancet, 2020, 396(10248): 413-446.
|
| [8] |
Ramos-Cazorla P, Carazo-Barrios L, Reyes-Bueno J A, et al. Olfactory dysfunction as a biomarker for early diagnosis of cognitive impairment in patients with type 2 diabetes: a systematic review[J]. J Diabetes Res, 2024, 2024: 9933957. DOI: 10.1155/jdr/9933957.
|
| [9] |
Tian Q, An Y, Kitner-Triolo M H, et al. Associations of olfaction with longitudinal trajectories of brain volumes and neuropsychological function in older adults[J]. Neurology, 2023, 100(9): e917-e928. DOI: 10.1212/WNL.0000000000201646.
|
| [10] |
Xiao Z X, Wu W Q, Ma X X, et al. Olfactory function, neurofilament light chain, and cognitive trajectory: a 12-year follow-up of the Shanghai Aging Study[J]. Alzheimers Dement, 2023, 15(4): e12485. DOI: 10.1002/dad2.12485.
|
| [11] |
Roberts R O, Christianson T J H, Kremers W K, et al. Association between olfactory dysfunction and amnestic mild cognitive impairment and Alzheimer disease dementia[J]. JAMA Neurol, 2016, 73(1): 93-101. DOI: 10.1001/jamaneurol.2015.2952.
|
| [12] |
Dintica C S, Marseglia A, Rizzuto D, et al. Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain[J]. Neurology, 2019, 92(7): e245-e253. DOI: 10.1212/WNL.0000000000006919.
|
| [13] |
Zhang Z, Zhang B, Wang X, et al. Altered odor-induced brain activity as an early manifestation of cognitive decline in patients with type 2 diabetes[J]. Diabetes, 2018, 67(5): 994-1006. DOI: 10.2337/db17-1274.
|
| [14] |
|
| [15] |
Lafaille-Magnan M E, Poirier J, Etienne P, et al. Odor identification as a biomarker of preclinical AD in older adults at risk[J]. Neurology, 2017, 89(4): 327-335. DOI: 10.1212/WNL.0000000000004159.
|
| [16] |
Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539:AID-DIA668>3.0.CO;2-S.
|
| [17] |
翁心植,邱鹤庚. 世界卫生组织(WHO)关于吸烟情况调查方法标准化的建议(节译)[J]. 心肺血管病杂志, 1984, 3(1): 21-26.
|
| [18] |
Reilly K H, Gu D F, Duan X F, et al. Risk factors for chronic obstructive pulmonary disease mortality in Chinese adults[J]. Am J Epidemiol, 2008, 167(8): 998-1004. DOI: 10.1093/aje/kwm393.
|
| [19] |
Petersen R C, Lopez O, Armstrong M J, et al. Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology[J]. Neurology, 2018, 90(3): 126-135. DOI: 10.1212/WNL.0000000000004826.
|
| [20] |
Nasreddine Z S, Phillips N A, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc, 2005, 53(4): 695-699. DOI: 10.1111/j.1532-5415.2005.53221.x.
|
| [21] |
Thomann P A, Dos Santos V, Seidl U, et al. MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease[J]. J Alzheimers Dis, 2009, 17(1): 213-221.
|
| [22] |
Jobin B, Boller B, Frasnelli J. Volumetry of olfactory structures in mild cognitive impairment and Alzheimer's disease: a systematic review and a meta-analysis[J]. Brain Sci, 2021, 11(8): 1010. DOI: 10.3390/brainsci11081010.
|
| [23] |
Tonacci A, Bruno R M, Ghiadoni L, et al. Olfactory evaluation in mild cognitive impairment: correlation with neurocognitive performance and endothelial function[J]. Eur J Neurosci, 2017, 45(10): 1279-1288. DOI: 10.1111/ejn.13565.
|
| [24] |
Dong Y, Li Y J, Liu K K, et al. Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults[J]. Alzheimers Dement, 2023, 19(2): 589-601. DOI: 10.1002/alz.12777.
|
| [25] |
Wu J, Yin X J, Liu Y, et al. The combined effects of visual impairment, hearing loss, and olfactory dysfunction on cognitive impairment: an individually matched case-control study[J]. Alzheimers Dement, 2025, 21(8): e70439. DOI: 10.1002/alz.70439.
|
| [26] |
Kim S J, Windon M J, Lin S Y. The association between diabetes and olfactory impairment in adults: a systematic review and meta-analysis[J]. Laryngoscope Investig Otolaryngol, 2019, 4(5): 465-475. DOI: 10.1002/lio2.291.
|
| [27] |
Zaghloul H, Pallayova M, Al-Nuaimi O, et al. Association between diabetes mellitus and olfactory dysfunction: current perspectives and future directions[J]. Diabet Med, 2018, 35(1): 41-52. DOI: 10.1111/dme.13542.
|
| [28] |
Midorikawa M, Suzuki H, Suzuki Y, et al. Relationships between cognitive function and odor identification, balance capability, and muscle strength in middle-aged persons with and without type 2 diabetes[J]. J Diabetes Res, 2021, 2021: 9961612. DOI: 10.1155/2021/9961612.
|
| [29] |
Sanke H, Mita T, Yoshii H, et al. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus[J]. Diabetes Res Clin Pract, 2014, 106(3): 465-473. DOI: 10.1016/j.diabres.2014.09.039.
|
| [30] |
Wang N, Chen X. Diagnostic value of Montreal Cognitive Assessment combined with olfactory tests for mild cognitive impairment in older adult patients with type 2 diabetes[J]. Eur Geriatr Med, 2025, 16(5): 1639-1646. DOI: 10.1007/s41999-025-01223-x.
|
| [31] |
Quarmley M, Moberg P J, Mechanic-Hamilton D, et al. Odor identification screening improves diagnostic classification in incipient Alzheimer's disease[J]. J Alzheimers Dis, 2017, 55(4): 1497-1507. DOI: 10.3233/JAD-160842.
|
| [32] |
Kim H R, Kim S M, Seong W, et al. Cut-off scores of an olfactory function test for mild cognitive impairment and dementia[J]. Psychiatry Investig, 2020, 17(10): 1021-1030. DOI: 10.30773/pi.2020.0203.
|
| [33] |
Gao Y, Liu Y C, Zhang Y, et al. Olfactory threshold test as a quick screening tool for cognitive impairment: analysis of two independent cohorts[J]. J Alzheimers Dis, 2023, 93(1): 169-178.
|
| [34] |
Mi Y, Ma X J, Du S, et al. Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease[J]. Front Aging Neurosci, 2023, 15: 1068708.
|